NASDAQ:SWAV Shockwave Medical (SWAV) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$334.75▼$334.7550-Day Range$328.87▼$334.8352-Week Range$157.00▼$334.90VolumeN/AAverage Volume968,088 shsMarket Capitalization$12.57 billionP/E Ratio78.21Dividend YieldN/APrice Target$309.11 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Get Shockwave Medical alerts: Email Address Shockwave Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.09 Rating ScoreUpside/Downside7.7% Downside$309.11 Price TargetShort InterestN/ADividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth21.98%From $5.05 to $6.16 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.33 out of 5 starsMedical Sector765th out of 936 stocksSurgical & Medical Instruments Industry86th out of 101 stocks 1.0 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 1 buy rating, 10 hold ratings, and no sell ratings.Amount of Analyst CoverageShockwave Medical has received no research coverage in the past 90 days.Read more about Shockwave Medical's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SWAV. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 1 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions95.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Shockwave Medical's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 21.98% in the coming year, from $5.05 to $6.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 16.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Shockwave Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Shockwave Medical Stock (NASDAQ:SWAV)Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here SWAV Stock News HeadlinesMay 22, 2024 | benzinga.comTrinh Phung At Shockwave Medical Capitalizes: Options Exercised, Resulting In $6.48MMay 21, 2024 | msn.comShockwave Medical gains after HSR waiting period for sale to J&J expiresJuly 26, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 16, 2024 | seekingalpha.comShockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson InvestorsMay 13, 2024 | msn.comJ&J’s $13 billion bid for Shockwave turns to Wall Street for fundingMay 9, 2024 | markets.businessinsider.comMaintaining Hold: Shockwave Medical’s Solid Performance Tempered by Market ValuationMay 9, 2024 | businesswire.comSHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAVMay 7, 2024 | markets.businessinsider.comHold Rating Justified for Shockwave Medical Amidst Strong Performance and Pending Johnson & Johnson AcquisitionJuly 26, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 7, 2024 | msn.comShockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/YMay 7, 2024 | finance.yahoo.comBeyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)May 6, 2024 | globenewswire.comShockwave Medical Reports First Quarter 2024 Financial ResultsApril 26, 2024 | benzinga.comMonthly Depth Report: The Blind Leading The ConfusedApril 24, 2024 | finance.yahoo.comShockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial ResultApril 18, 2024 | msn.comShockwave Medical (SWAV) Price Target Increased by 17.23% to 322.46April 16, 2024 | finance.yahoo.comJ&J CFO on Q1 Earnings, Forecast and Product PipelineApril 12, 2024 | finance.yahoo.comPharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory NewsApril 12, 2024 | finance.yahoo.comShockwave Medical (SWAV) Rose on Strong Financial ResultsSee More Headlines Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today7/26/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,468Year FoundedN/APrice Target and Rating Average Stock Price Target$309.11 High Stock Price Target$368.00 Low Stock Price Target$210.00 Potential Upside/Downside-7.7%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$4.28 Trailing P/E Ratio78.21 Forward P/E Ratio66.29 P/E Growth2.43Net Income$147.28 million Net Margins20.75% Pretax Margin23.29% Return on Equity24.79% Return on Assets11.95% Debt Debt-to-Equity Ratio0.97 Current Ratio13.81 Quick Ratio12.61 Sales & Book Value Annual Sales$787.97 million Price / Sales15.95 Cash Flow$4.31 per share Price / Cash Flow77.61 Book Value$20.02 per share Price / Book16.72Miscellaneous Outstanding Shares37,544,000Free Float36,268,000Market Cap$12.57 billion OptionableOptionable Beta0.88 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Douglas E. Godshall M.B.A. (Age 59)President, CEO & Director Comp: $1.57MMr. Daniel Hawkins (Age 57)Founder and Senior Advisor Mr. John M. Adams (Age 77)Co-Founder and Technical Advisor Ms. Renee M. Gaeta (Age 43)Chief Financial Officer Mr. Luis MoralesSenior Vice President of Global OperationsMs. Trinh Phung (Age 46)Chief Accounting Officer, Principal Accounting Officer & VP of Finance Ms. Debbie KasterVice President of Investor RelationsMr. Hajime Tada J.D.General Counsel & SecretaryMr. Robert FletcherSenior Vice President of Marketing & Market AccessMr. Dave CoxVice President of SalesMore ExecutivesKey CompetitorsCantel MedicalNYSE:CMDNuVasiveNASDAQ:NUVACardiovascular SystemsNASDAQ:CSIIDexComNASDAQ:DXCMResMedNYSE:RMDView All CompetitorsInsiders & InstitutionsBlue Trust Inc.Bought 158 shares on 7/18/2024Ownership: 0.000%Tactive Advisors LLCBought 800 shares on 6/4/2024Ownership: 0.002%DekaBank Deutsche GirozentraleSold 244 shares on 6/4/2024Ownership: 0.001%Verity Asset Management Inc.Sold 260 shares on 5/28/2024Ownership: 0.013%Cetera Advisors LLCBought 620 shares on 5/24/2024Ownership: 0.002%View All Insider TransactionsView All Institutional Transactions SWAV Stock Analysis - Frequently Asked Questions How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, May, 6th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.99 by $0.45. The firm's quarterly revenue was up 35.8% on a year-over-year basis. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. When did Shockwave Medical IPO? Shockwave Medical (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. Who are Shockwave Medical's major shareholders? Top institutional investors of Shockwave Medical include Blue Trust Inc.. Insiders that own company stock include Frederic H Moll, Douglas Evan Godshall, Isaac Zacharias, Trinh Phung, Dan Puckett, Antoine Papiernik, Maria Sainz, Frank T Watkins, Sara Toyloy and Laura Francis. View institutional ownership trends. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU) and PayPal (PYPL). This page (NASDAQ:SWAV) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shockwave Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
